Hasil Pencarian - Dafna D Gladman

Perbaiki Hasil
  1. 1
    Recent advances in understanding and managing psoriatic arthritis [version 1; referees: 2 approved]

    Recent advances in understanding and managing psoriatic arthritis [version 1; referees: 2 approved] oleh Dafna D. Gladman

    Diterbitkan 2016-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus

    Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus oleh Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis.

    Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. oleh Remy A Pollock, Laila Zaman, Vinod Chandran, Dafna D Gladman

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The association between sonographic enthesitis and radiographic damage in psoriatic arthritis

    The association between sonographic enthesitis and radiographic damage in psoriatic arthritis oleh Ari Polachek, Richard Cook, Vinod Chandran, Dafna D. Gladman, Lihi Eder

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis

    Correction to: The association between sonographic enthesitis and radiographic damage in psoriatic arthritis oleh Ari Polachek, Richard Cook, Vinod Chandran, Dafna D. Gladman, Lihi Eder

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research

    Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research oleh Désirée van der Heijde, Dafna D. Gladman, Arthur Kavanaugh, Philip J. Mease

    Diterbitkan 2020-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis

    Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis oleh Alexis Ogdie, Dafna D. Gladman, Laura C. Coates, Effie Pournara, Bhumik Parikh, Philip J. Mease

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study

    Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-... oleh Philip J Mease, Dafna D Gladman, Laura C Coates, Sandra Navarra, Corine Gaillez, Weibin Bao

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    1303 The new EULAR/ACR 2019 SLE classification criteria: a predictor of long-term outcomes

    1303 The new EULAR/ACR 2019 SLE classification criteria: a predictor of long-term outcomes oleh Murray B Urowitz, Dafna D Gladman, Sindhu R Johnson, Jiandong Su, Zahi Touma, Laura Whittall-Garcia

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis

    Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis oleh Dafna D Gladman, Murray Urowitz, Zahi Touma, Joan Wither, Laura Patricia Whittall-Garcia, Farnoosh Naderinabi, Ana Konvalinka

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis

    1117 Neutrophil extracellular traps as a biomarker to predict outcomes in lupus nephritis oleh Murray B Urowitz, Dafna D Gladman, Zahi Touma, Joan Wither, Laura Whittall-Garcia, Farnoosh Naderinavi, Anna Konvalinka

    Diterbitkan 2022-12-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients

    Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patient... oleh Lily Siok Hoon Lim, Eleanor Pullenayegum, Rahim Moineddin, Dafna D Gladman, Earl D Silverman, Brian M Feldman

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHC

    Integrative Approach to Reveal Cell Type Specificity and Gene Candidates for Psoriatic Arthritis Outside the MHC oleh Matthew T. Patrick, Philip E. Stuart, Kalpana Raja, Kalpana Raja, Sunyi Chi, Sunyi Chi, Zhi He, John J. Voorhees, Trilokraj Tejasvi, Trilokraj Tejasvi, Johann E. Gudjonsson, J. Michelle Kahlenberg, Vinod Chandran, Vinod Chandran, Vinod Chandran, Vinod Chandran, Vinod Chandran, Proton Rahman, Dafna D. Gladman, Dafna D. Gladman, Dafna D. Gladman, Rajan P. Nair, James T. Elder, James T. Elder, Lam C. Tsoi, Lam C. Tsoi, Lam C. Tsoi

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus

    The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus oleh Lloyd Mai, Arundip Asaduzzaman, Babak Noamani, Paul R. Fortin, Dafna D. Gladman, Zahi Touma, Murray B. Urowitz, Joan Wither

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Classification and Outcome Measures for Psoriatic Arthritis

    Classification and Outcome Measures for Psoriatic Arthritis oleh Ying Ying Leung, Alexis Ogdie, Ana-Maria Orbai, William Tillett, Laura C. Coates, Vibeke Strand, Philip Mease, Dafna D. Gladman

    Diterbitkan 2018-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis

    Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1–3 pooled analysis oleh Arthur Kavanaugh, Dafna D. Gladman, Christopher J. Edwards, Georg Schett, Benoit Guerette, Nikolay Delev, Lichen Teng, Maria Paris, Philip J. Mease

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo

    Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo oleh Dafna D. Gladman, Laura C. Coates, Joseph Wu, Lara Fallon, Elizabeth D. Bacci, Joseph C. Cappelleri, Andrew G. Bushmakin, Philip S. Helliwell

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

    Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data oleh Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib

    Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib oleh Laura C. Coates, Andrew G. Bushmakin, Oliver FitzGerald, Dafna D. Gladman, Lara Fallon, Joseph C. Cappelleri, Ming-Ann Hsu, Philip S. Helliwell

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs

    Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to con... oleh Philip J Mease, Dafna D Gladman, Vibeke Strand, Kurt de Vlam, Daniela Graham, Cunshan Wang, Joseph C Cappelleri, Thijs Hendrikx, Ming-Ann Hsu

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: